Sapiens price target raised to $31 from $28 at Barclays

Barclays raised the firm’s price target on Sapiens (SPNS) to $31 from $28 and keeps an Underweight rating on the shares post the Q1 report. Sapiens is continuing with its strategy-optimizing product offerings and leveraging its existing customer base, this quarter making two acquisitions, the analyst tells investors in a research note. The firm thinks it is too early to become constructive on the shares.